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Fig 2. The designed biomaterial 
consists of a hydrogel (PEG) 
scaffold with encapsulated 
growth factors as VEGF and 
PDGF-BB, coating with heparin 
(an antithrombotic enzyme) and 
endothelial cells cultivated over 
it.  
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To determine if the designed biomaterial can prevent the blood coagulation at the same time that it acts as a scaffold, testing it in vitro. 
We have proposed a method to test the hemocompatibility of a new modified hydrogel-based biomaterial has been proposed. If the results are 
promising, it could bring the chance  of using a new biomaterial capable of avoiding coagulation while maintaining its mechanical and chemical 
propierties.  
By coating the hydrogel with heparin, the likelihood of gaps in direct contact with the blood would be bypassed, while encapsulating growth factors 
inside would allow inducing a controlled attachment of endothelial cells.  
This hypothetic new biomaterial could have a great potential for tissue-engineering, but more assays should be done before determining their full 
functionality.  
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Over the last several years, a lot of advances in cell biology have opened the door to 
regenerative medicine, both at tissue and organ level. Promoting the culture of these tissues is 
troublesome, and it usually requires a complex setup in 3D. To facilitate the three-dimensional 
tissue formation, an scaffold is often employed. It consists of a support (biological or synthetic) 
that allows cell attachment and growth in an organized way1.  
 
There are a lot of different biomaterials with diverse characteristics that can be used as 
scaffold,  depending on the tissue we want to reproduce. Nowadays, one of the most employed 
biomaterials are  hydrogels, due their mechanical and physical properties, their stability at 
physiological pH and temperature and because it has been proved that they are not cytotoxic to 
the surrounding tissue 2. 
 
Unfortunately, the contact of the blood directly with the scaffold surface promotes unspecific 
protein adsorption, which entails blood cells adhesion, like platelet or erythrocytes and finishes 
in intrinsic coagulation pathway activation. This coagulation ends creating a thrombus, which 
can obstruct the blood flow through the circulatory system, causing hypoxia and the subsequent 
organ or tissue atrophy, or even an embolism if the thrombus becomes detached3. Preventing 
thrombosis is currently one of the major challenges for biomaterials.  
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Methodology 
In order to validate the thrombogenicity of the designed material several analyses will be 
performed. The studies will be done on perfusion systems, where blood is kept in 
movement at a given velocity. 
 
Blood will be obtained from healthy donors, and treated in advance with a small heparin 
dose (1U/ml) to prevent coagulation until the start of the experiment. The blood will be 
recirculated through the circuit showed in Fig 3. 
The blood will be analysed before and after the incubation step in the circuit. Cell 
number will be measured using a Coulter Counter. ELISA assays will be performed to 
quantify the presence of components characteristic of coagulation (such as thrombin-
antithrombin), immune response (C5a, C3a), platelet activation (platelet factor 4) and 
leukocyte activation (Elastase). 
Hemolysis will be tested via free hemoglobin quantification in plasma.  
 
Cell adhesion to the material’s surface and any morphology changes will be examined 
using Scanning Electron Microscopy (SEM) and by Confocal Microscopy. 
 
 
Fig 3. Blood will be recirculated through a circuit consisted of 3mm 
diameter silicone tubes, a section with valves that allow the affluence 
and exit of blood from a reservoir, a roller pump to regulate the blood 
flow and the incubator chamber. In order to maintain the pH value, CO2 
and temperature constant, all the experiments will take place in an 
incubator4. 
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Fig 1. Desirable characteristics 
in biomaterials. 
